211 related articles for article (PubMed ID: 32847529)
21. Autosomal dominant tubulointerstitial kidney disease: A review.
Živná M; Kidd KO; Barešová V; Hůlková H; Kmoch S; Bleyer AJ
Am J Med Genet C Semin Med Genet; 2022 Sep; 190(3):309-324. PubMed ID: 36250282
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of C/EBP Homologous Protein induced by ER Stress Mediates Epithelial to Myofibroblast Transformation in ADTKD-UMOD.
Wang D; Qiu Y; Fan J; Liu Y; Chen W; Li Z; Chen W; Wang X
Int J Med Sci; 2022; 19(2):364-376. PubMed ID: 35165522
[TBL] [Abstract][Full Text] [Related]
23. From juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis.
Venkat-Raman G; Gast C; Marinaki A; Fairbanks L
Pediatr Nephrol; 2016 Nov; 31(11):2035-42. PubMed ID: 26872483
[TBL] [Abstract][Full Text] [Related]
24. An intermediate-effect size variant in
Olinger E; Schaeffer C; Kidd K; Elhassan EAE; Cheng Y; Dufour I; Schiano G; Mabillard H; Pasqualetto E; Hofmann P; Fuster DG; Kistler AD; Wilson IJ; Kmoch S; Raymond L; Robert T; ; Eckardt KU; Bleyer AJ; Köttgen A; Conlon PJ; Wiesener M; Sayer JA; Rampoldi L; Devuyst O
Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2114734119. PubMed ID: 35947615
[TBL] [Abstract][Full Text] [Related]
25. Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific?
Onoe T; Hara S; Yamada K; Zoshima T; Mizushima I; Ito K; Mori T; Daimon S; Muramoto H; Shimizu M; Iguchi A; Kuma A; Ubara Y; Mitobe M; Tsuruta H; Kishimoto N; Imura J; Konoshita T; Kawano M
BMC Nephrol; 2021 Jan; 22(1):1. PubMed ID: 33397327
[TBL] [Abstract][Full Text] [Related]
26. Autosomal Dominant Tubulointerstitial Kidney Disease-Uromodulin Misclassified as Focal Segmental Glomerulosclerosis or Hereditary Glomerular Disease.
Chun J; Wang M; Wilkins MS; Knob AU; Benjamin A; Bu L; Pollak MR
Kidney Int Rep; 2020 Apr; 5(4):519-529. PubMed ID: 32274456
[TBL] [Abstract][Full Text] [Related]
27. Type of uromodulin mutation and allelic status influence onset and severity of uromodulin-associated kidney disease in mice.
Kemter E; Prueckl P; Sklenak S; Rathkolb B; Habermann FA; Hans W; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Wolf E; Aigner B; Wanke R
Hum Mol Genet; 2013 Oct; 22(20):4148-63. PubMed ID: 23748428
[TBL] [Abstract][Full Text] [Related]
28. SPTB related spherocytosis in a three-generation family presenting with kidney failure in adulthood due to co-occurrence of UMOD disease causing variant.
Meglic A; Debeljak M; Kovac J; Trampus Bakija A; Rajic V; Kojc N; Trebusak Podkrajsek K
Nefrologia (Engl Ed); 2020; 40(4):421-428. PubMed ID: 32113667
[TBL] [Abstract][Full Text] [Related]
29. Autosomal dominant tubulointerstitial kidney disease genotype and phenotype correlation in a Chinese cohort.
Gong K; Xia M; Wang Y; Wang N; Liu Y; Zhang VW; Cheng H; Chen Y
Sci Rep; 2021 Feb; 11(1):3615. PubMed ID: 33574344
[TBL] [Abstract][Full Text] [Related]
30. Novel UMOD mutations in familial juvenile hyperuricemic nephropathy lead to abnormal uromodulin intracellular trafficking.
Liu M; Chen Y; Liang Y; Liu Y; Wang S; Hou P; Zhang H; Zhao M
Gene; 2013 Dec; 531(2):363-9. PubMed ID: 23988501
[TBL] [Abstract][Full Text] [Related]
31. Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.
Bleyer AJ; Wolf MT; Kidd KO; Zivna M; Kmoch S
Pediatr Nephrol; 2022 May; 37(5):933-946. PubMed ID: 34021396
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy.
Hart TC; Gorry MC; Hart PS; Woodard AS; Shihabi Z; Sandhu J; Shirts B; Xu L; Zhu H; Barmada MM; Bleyer AJ
J Med Genet; 2002 Dec; 39(12):882-92. PubMed ID: 12471200
[TBL] [Abstract][Full Text] [Related]
33. Autosomal Dominant Tubulointerstitial Kidney Disease.
Bleyer AJ; Kidd K; Živná M; Kmoch S
Adv Chronic Kidney Dis; 2017 Mar; 24(2):86-93. PubMed ID: 28284384
[TBL] [Abstract][Full Text] [Related]
34. A novel disease-causing mutation in the Renin gene in a Tunisian family with autosomal dominant tubulointerstitial kidney disease.
Abdelwahed M; Chaabouni Y; Michel-Calemard L; Chaabouni K; Morel Y; Hachicha J; Makni FA; Kamoun H; Ammar-Keskes L; Belghith N
Int J Biochem Cell Biol; 2019 Dec; 117():105625. PubMed ID: 31586593
[TBL] [Abstract][Full Text] [Related]
35. A novel HNF1B mutation p.R177Q in autosomal dominant tubulointerstitial kidney disease and maturity-onset diabetes of the young type 5: A pedigree-based case report.
Tao T; Yang Y; Hu Z
Medicine (Baltimore); 2020 Jul; 99(31):e21438. PubMed ID: 32756155
[TBL] [Abstract][Full Text] [Related]
36. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.
Eckardt KU; Alper SL; Antignac C; Bleyer AJ; Chauveau D; Dahan K; Deltas C; Hosking A; Kmoch S; Rampoldi L; Wiesener M; Wolf MT; Devuyst O;
Kidney Int; 2015 Oct; 88(4):676-83. PubMed ID: 25738250
[TBL] [Abstract][Full Text] [Related]
37. Wild-type uromodulin prevents NFkB activation in kidney cells, while mutant uromodulin, causing FJHU nephropathy, does not.
Dinour D; Ganon L; Nomy LI; Ron R; Holtzman EJ
J Nephrol; 2014 Jun; 27(3):257-64. PubMed ID: 24648000
[TBL] [Abstract][Full Text] [Related]
38. Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease.
Schiano G; Lake J; Mariniello M; Schaeffer C; Harvent M; Rampoldi L; Olinger E; Devuyst O
EMBO Mol Med; 2023 Dec; 15(12):e18242. PubMed ID: 37885358
[TBL] [Abstract][Full Text] [Related]
39. Familial juvenile hyperuricemia in early childhood in a boy with a novel gene mutation.
Takemasa Y; Hirano D; Kawakami Y; Tokunaga A; Umeda C; Miwa S; Kakegawa D; Ito A; Ida H
CEN Case Rep; 2021 Aug; 10(3):426-430. PubMed ID: 33616882
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
